Excellence & Innovation in GI cancer research since 1991

For 25 years, the Australasian Gastro-Intestinal Trials Group has been conducting and promoting clinical and related biological research in Australasia and internationally, addressing key unanswered questions to achieve better health outcomes for patients with GI cancer.

Timeline Images1
  • AGITG opens first clinical trials to patient participation under the auspices of the NHMRC Clinical Trials Centre, University of Sydney – two colorectal cancer studies from the USA
Timeline Images2
  • AGITG developed first trials for colorectal cancer and oesophageal cancer
  • Professor John Zalcberg OAM appointed Chair of the AGITG
Timeline Images3
  • First AGITG developed gastric cancer trial opens to patient participation
Timeline Images4
  • First AGITG Annual Scientific Meeting (ASM) held in Launceston, TAS
Timeline Images5
  • AGITG incorporated as Company Limited by Guarantee
  • First Board of Directors elected
  • Recruitment opens for patients for colorectal cancer clinical trials
Timeline Images6
  • AGITG and Trans Tasman Radiation Oncology Group (TROG) collaborate to develop a trial for rectal cancer patients
  • AGITG participates in trials developed by the European Organisation for Research and Treatment of Cancer (EORTC)
  • AGITG participates in trials for gastro-oesophageal cancer, advanced gastro-intestinal stromal tumours (GIST), advanced hepatocellular carcinoma and liver cancer


   Timeline Images7
  •  AGITG accrues patients to a pancreatic cancer trial developed by the National Cancer Institute of Canada (NCIC)
  • AGITG collaborates with European Study Group for Pancreatic Cancer (ESPAC) for the first time for a pancreatic cancer trial
  • AGITG’s Gastro-Intestinal  Cancer Institute of Australia and New Zealand is launched and hosts public information forum


 Timeline Images8
  •  AGITG and the NCIC collaborate to develop a colorectal cancer clinical trial
 Timeline Images9
  •  First AGITG developed oesophago-gastric cancer trial
  • Advanced GIST study results published in the Lancet
 Timeline Images10
  •  His Honor Judge Alan Bishop is the first non-clinician to join the AGITG Board of Directors
  • First AGITG developed trial in colorectal cancer to accrue patients internationally
  • New Concepts Symposium is introduced at the AGITG Annual Scientific Meeting
  • First Research Fellow appointed
  • AGITG trials for oesophageal cancer, GIST, biliary tract, pancreatic, and colorectal cancer
Timeline Images11
  • First Cancer Australia infrastructure grant ‘Strengthening Cancer Carer’ awarded to AGITG
  • GI Cancer Institute held ‘Kick a Goal for Bowel Cancer’ in Martin Place, Sydney to raise awareness of the disease
Timeline Images12
  • AGITG meta-analysis for treatment of oesophageal cancer published in Lancet Oncology
  • CO.17 study results in New England Journal of Medicine
  • CO7 trial results published in journal of Clinical Oncology
  • AGITG collaborates with the University of Oxford to conduct a colorectal cancer clinical trial
Timeline Images13
  • AGITG consumer Advisory Panel established
  • AGITG and the NCIC collaborate to develop a second colorectal cancer clinical trial
Timeline Images14
  • The Alan Bishop Fund for GIST Research is established
  • Four AGITG developed clinical trials were launched to investigate new treatments for oesophageal cancer, gastric cancer and gastro-intestinal stromal tumour
  • AGITG participates in a rectal cancer clinical trial led by the EORTC
Timeline Images15
  • Four AGITG developed clinical trials were launched to investigate new treatments for oesophago-gastric cancer, gastrointestinal stromal tumour, colorectal cancer and rectal cancer
  • AGITG participates in a pancreatic cancer trial led by Groupe Cooperateur Multidiciplinaire en Oncologie (GERCOR)
  • AGITG participates in a colorectal cancer trial led by Cancer Clinical Trials Unit, Scotland (CaCTUS)
  • MAX study results published in Journal of Clinical Oncology
  • The Gutsy Challenge for children is launched
Timeline Images16
  • AGITG developed and led a trial for colorectoral cancer
  • Upper and Lower GI Working Parties established to identify gaps in research and develop new research concepts
Timeline Images17
  • Five AGITG developed Clinical trials open to patient participation investigating new treatments for biliary tract cancer, pancreatic cancer, colorectal cancer and cancer of the oesophago-gastric junction
  • External Review of AGITG conducted by three world leaders in GI cancer research
  • The GI Cancer Institute Engage Program launched
Timeline Images18
  • AGITG and NCIC collaborate on the next colorectoral cancer trial
  • AGITG and the Australasian Pancreatic Club hold the inaugural Pancreas Cancer Research Workshop
  • The Gutsy Challenge further developed to include adults
  • Engage Community Forums develop
  • Three AGITG trials conducted in Europe, Korea and Canada for the First time
  • Best New Concept Award and Kristian Anderson Award Launched
  • First Preceptorship in Colorectal cancer held
Timeline Images19
  • Professor Tim Price appointed as Chair of the AGITG
  • AGITG collaborates with the Scandinavian Sarcoma Group to develop a trial for gastrointestinal stromal tumour
  • Aspirin based clinical trial for colorectal cancer led by an international collaboration from Australia, Singapore and UK opens to patient participation
Timeline Images20
  • Adjuvant GIST study results published in Journal of Clinical Oncology
  • AGITG membership grows to over 1,000
  • Results from INTEGRATE and GAP clinical trials are presented at American Society of Clinical Oncology Conference (ASCO) in Chicago
  • Pancreatic Cancer Surgical Guidelines Workshop held to develop national guidelines
  • Inaugural meeting of the Commonwealth Neuroendocrine Tumor Group (CommNETS)
  • Two AGITG innovation fund grants awarded
  • AGITG developed trial for neuroendocrine tumours